SAN FRANCISCO-Transwestern has brokered a lease for 13,271 square feet at 55 Francisco Street in a deal that doubled the headquarters of software services firm Endpoint Clinical Inc. The fast-growing company develops and provides technology systems to support an array of clinical trials in the life sciences industry. Terms of the lease were not disclosed.

“The founding team at Endpoint Clinical began developing advanced systems in 1998 for small, medium and large pharmaceutical companies, both domestic and worldwide,” said SVP Markus Shayeb, Transwestern's lead broker who represented Endpoint Clinical in the transaction. “It has a reputation for being the industry's best in design, engineering, testing, quality and service. The software is absolutely vital to studies in a wide range of therapeutic areas including oncology, hematology, dermatology, cardiovascular diseases, diabetes and many others.”

Transwestern's Shayeb teamed with Ben Durham, a partner at HMC Commercial Inc., in representing Endpoint Clinical. Dean McPadden of The CAC Group represented TR 55 Francisco LLC, a real estate investment trust that owns the building.